MA54503A - Arn codant pour une protéine - Google Patents

Arn codant pour une protéine

Info

Publication number
MA54503A
MA54503A MA054503A MA54503A MA54503A MA 54503 A MA54503 A MA 54503A MA 054503 A MA054503 A MA 054503A MA 54503 A MA54503 A MA 54503A MA 54503 A MA54503 A MA 54503A
Authority
MA
Morocco
Prior art keywords
protein
rna coding
rna
coding
Prior art date
Application number
MA054503A
Other languages
English (en)
Inventor
Friedrich Metzger
Hervé Schaffhauser
Justin Antony Selvaraj
Original Assignee
Versameb Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Versameb Ag filed Critical Versameb Ag
Publication of MA54503A publication Critical patent/MA54503A/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/62—DNA sequences coding for fusion proteins
    • C12N15/625—DNA sequences coding for fusion proteins containing a sequence coding for a signal sequence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A61K48/005—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the 'active' part of the composition delivered, i.e. the nucleic acid delivered
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Public Health (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Neurology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Toxicology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
MA054503A 2018-12-19 2019-12-18 Arn codant pour une protéine MA54503A (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP18214221 2018-12-19
EP19208066 2019-11-08

Publications (1)

Publication Number Publication Date
MA54503A true MA54503A (fr) 2021-10-27

Family

ID=68848313

Family Applications (1)

Application Number Title Priority Date Filing Date
MA054503A MA54503A (fr) 2018-12-19 2019-12-18 Arn codant pour une protéine

Country Status (18)

Country Link
US (1) US20220002364A1 (fr)
EP (1) EP3898982A2 (fr)
JP (1) JP2022514863A (fr)
KR (1) KR20210105382A (fr)
CN (1) CN113454227A (fr)
AU (1) AU2019407921A1 (fr)
BR (1) BR112021011771A2 (fr)
CA (1) CA3120638A1 (fr)
CL (1) CL2021001571A1 (fr)
CO (1) CO2021007916A2 (fr)
IL (1) IL284035A (fr)
MA (1) MA54503A (fr)
MX (1) MX2021007241A (fr)
PE (1) PE20211342A1 (fr)
PH (1) PH12021551135A1 (fr)
SG (1) SG11202105267VA (fr)
TW (1) TW202043477A (fr)
WO (1) WO2020127532A2 (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2022132666A1 (fr) 2020-12-14 2022-06-23 Regeneron Pharmaceuticals, Inc. Méthodes de traitement de troubles métaboliques et de maladies cardiovasculaires avec des inhibiteurs de la sous-unité bêta e de l'inhibine (inhbe)
CN117042723A (zh) * 2021-01-26 2023-11-10 西吉隆医疗股份有限公司 用于诱导抗原特异性免疫耐受的组合物、装置和方法
JP2024510924A (ja) * 2021-03-01 2024-03-12 ザ ジョンズ ホプキンス ユニバーシティ 効率的なプロテオミクス研究のための自己組織化（ｍｉｐｓａ）によるタンパク質の分子インデックス化
WO2022216944A1 (fr) * 2021-04-07 2022-10-13 Mayo Foundation For Medical Education And Research Procédés et matériaux d'inversion de l'instabilité de la plaque d'athérome
MX2023012254A (es) * 2021-04-19 2023-10-24 Versameb Ag Metodo para tratar sintomas de las vias urinarias inferiores.
BR112023026961A2 (pt) * 2021-06-23 2024-03-12 Versameb Ag Composições e métodos para modular a expressão de genes
WO2024189146A1 (fr) * 2023-03-15 2024-09-19 Versameb Ag Arn codant pour une protéine

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1857122T3 (da) 2001-06-05 2011-03-21 Curevac Gmbh Stabiliseret mRNA med forøget G/C-indhold, kodende for et viralt antigen
DE102005046490A1 (de) 2005-09-28 2007-03-29 Johannes-Gutenberg-Universität Mainz Modifikationen von RNA, die zu einer erhöhten Transkriptstabilität und Translationseffizienz führen
WO2007071363A2 (fr) * 2005-12-22 2007-06-28 Embl European Molecular Biology Laboratory Procedes d'utilisation du variant de calcineurine a cna?1
EP2281047B1 (fr) * 2008-04-15 2020-04-08 Genzyme Corporation Procédés de production du facteur rdcvf
ES2687415T3 (es) * 2010-11-22 2018-10-25 Amicus Therapeutics, Inc. Nuevas secuencias señal para mejorar las expresiones de proteínas y la secreción de enzimas recombinantes y de otras proteínas
AU2012321102C1 (en) * 2011-10-27 2016-11-10 Pharma Cinq, Llc Vectors encoding rod-derived cone viability factor
CA2877384C (fr) * 2012-07-02 2023-05-09 Iprogen Biotech Inc. Administration intracellulaire de proteines
JP6644717B2 (ja) * 2014-03-14 2020-02-12 ジェネンテック， インコーポレイテッド 異種ポリペプチドを分泌させるための方法及び組成物
US20170183389A1 (en) * 2014-04-24 2017-06-29 Accurna, Inc. Method for improving protein expression, and composition for protein expression
GB2547179A (en) * 2015-10-26 2017-08-16 Quethera Ltd Genetic construct
GB201705484D0 (en) * 2017-04-05 2017-05-17 Quethera Ltd Genetic construct

Also Published As

Publication number Publication date
EP3898982A2 (fr) 2021-10-27
IL284035A (en) 2021-08-31
CL2021001571A1 (es) 2022-04-18
CN113454227A (zh) 2021-09-28
MX2021007241A (es) 2021-09-23
PH12021551135A1 (en) 2022-02-28
SG11202105267VA (en) 2021-07-29
WO2020127532A2 (fr) 2020-06-25
KR20210105382A (ko) 2021-08-26
PE20211342A1 (es) 2021-07-26
CA3120638A1 (fr) 2020-06-25
BR112021011771A2 (pt) 2021-08-31
WO2020127532A3 (fr) 2020-09-17
CO2021007916A2 (es) 2021-09-20
JP2022514863A (ja) 2022-02-16
US20220002364A1 (en) 2022-01-06
TW202043477A (zh) 2020-12-01
AU2019407921A1 (en) 2021-06-10

Similar Documents

Publication Publication Date Title
MA54503A (fr) Arn codant pour une protéine
DK3844147T3 (da) Forbindelser
MA44479A (fr) Arn transrepliquant
DE102020112518B8 (de) Toner
DK3737402T3 (en) Modificeret protein
IL280400A (en) Nucleic acids encode enhanced transaminase proteins
DK3840767T3 (da) Peptider
DK3738452T3 (da) Fordamper
GB2591896B (en) Extended merge prediction
IL291310A (en) aav-compatible proteins for polymerization bind to laminin
EP3813871A4 (fr) Protéines de métabolisation de sphingolipides codant pour un anc80
EP3762495A4 (fr) Modarn codant des protéines métabolisant les sphingolipides
TH1902002480S (th) แกลลอน
TH190908S (th) ถัง
UA42087S (uk) Несесер дорожній
UA42086S (uk) Несесер дорожній
UA42085S (uk) Несесер дорожній
UA42084S (uk) Несесер дорожній
UA42083S (uk) Несесер дорожній
GB201909710D0 (en) Proteins
TH182985B (th) แกลลอน
TH182984B (th) แกลลอน
ES1223104Y (es) Bloque apilable
UA39836S (uk) Лінійка зростова криміналістична
IT201900020859A1 (it) Bevanda migliorata